Table 4.
Number of samples and patients which were examined for MRP and NDM
| Samples (n) | Patients (n Total; Women %) | Samples with not Detectable Parent Substance |
|---|---|---|
| 63 | 38 (60.3) | 1 |
Number of samples and patients which were examined for MRP and NDM
| Samples (n) | Patients (n Total; Women %) | Samples with not Detectable Parent Substance |
|---|---|---|
| 63 | 38 (60.3) | 1 |